ERS Genomics

ERS Genomics

ERS Genomics was formed to provide broad access to CRISPR-Cas9 intellectual property held by Dr. Emmanuelle Charpentier, co-inventor and co-owner. Licenses are available to companies for internal research and sale of products and services.

ERS Genomics was formed to provide broad access to CRISPR-Cas9 intellectual property held by Dr. Emmanuelle Charpentier, co-inventor and co-owner. Licenses are available to companies for internal research and sale of products and services.

Timeline

People

Name
Role
LinkedIn

Emmanuelle Charpentier

Co-founder

Shaun Foy

Co-founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Alex Keown
December 3, 2020
BioSpace
Biopharma and life sciences companies from across the globe provide updates on their business and pipelines.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.